Evidence map›Paper›PMID 26894388›Full record

ArticleJournal of the International AIDS Society2016

Closer to 90-90-90. The cascade of care after 10 years of ART scale-up in rural Malawi: a population study.

David Maman, Benson Chilima, Charles Masiku, Ahidjo Ayouba, Sophie Masson, Elisabeth Szumilin, Martine Peeters, Nathan Ford, Annette Heinzelmann, Benjamin Riche and 1 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David MamanEpicentre, Paris, France; david.maman@epicentre.msf.org.
Benson ChilimaMinistry of Health, Lilongwe, Malawi.
Charles MasikuMédecins Sans Frontières, Lilongwe, Malawi.
Ahidjo AyoubaUMI 233 TransVIHMI, Institut de Recherche pour le Développement (IRD), Montpellier 1 University, Montpellier, France.
Sophie MassonEpicentre, Paris, France.
Elisabeth SzumilinMédecins Sans Frontières, Paris, France.
Martine PeetersUMI 233 TransVIHMI, Institut de Recherche pour le Développement (IRD), Montpellier 1 University, Montpellier, France.
Nathan FordCentre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Annette HeinzelmannMédecins Sans Frontières, Paris, France.
Benjamin RicheService de Biostatistique, Hospices Civils de Lyon, Lyon, France.
Jean-François EtardEpicentre, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe antiretroviral therapy (ART) programme supported by Médecins Sans Frontières in the rural Malawian district of Chiradzulu was one of the first in sub-Saharan Africa to scale up ART delivery in 2002. After more than a decade of continuous involvement, we conducted a population survey to evaluate the cascade of care, including population viral load, in the district.

methodsA cross-sectional household-based survey was conducted between February and May 2013. Using a multistage cluster sampling method, we recruited all individuals aged 15 to 59 years living in 4125 randomly selected households. Each consenting individual was interviewed and tested for HIV at home. All participants who tested positive had their CD4 count and viral load measured. The LAg-Avidity assay was used to distinguish recent from long-term infections. Viral suppression was defined as a viral load below 1000 copies/mL.

resultsOf 8271 individuals eligible for the study, 7269 agreed to participate and were tested for HIV (94.1% inclusion for women and 80.3% for men). Overall HIV prevalence and incidence were 17.0% (95% CI 16.1 to 17.9) and 0.39 new cases per 100 person-years (95% CI 0.0 to 0.77), respectively. Coverage at the other steps along the HIV care cascade was as follows: 76.7% (95% CI 74.4 to 79.1) had been previously diagnosed, 71.2% (95% CI 68.6 to 73.6) were under care and 65.8% (95% CI 62.8 to 68.2) were receiving ART. Finally, the proportion of participants who were HIV positive with a viral load ≤ 1000 copies/mL reached 61.8% (95% CI 59.0 to 64.5).

conclusionsThis study demonstrates that a high level of population viral suppression and low incidence can be achieved in high HIV prevalence and resource-limited settings.

Indexed as

AdolescentAdultAnti-HIV AgentsCross-Sectional StudiesFemaleHIV InfectionsHumansIncidenceMalawiMaleMiddle AgedPrevalenceRural PopulationViral LoadAnti-HIV AgentsHIVincidenceprevalenceviral load

Identifiers

PMID26894388
PMCPMC4760102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.